187 related articles for article (PubMed ID: 14587168)
1. Pharmacological reperfusion in acute myocardial infarction after ASSENT 3 and GUSTO V.
Ferreira D
Rev Port Cardiol; 2003; 22(7-8):1005-9. PubMed ID: 14587168
[No Abstract] [Full Text] [Related]
2. [Reperfusion after acute myocardial infarct with fibrinolytic therapy o combination reduced fibrinolytic therapy and a glycoprotein IIb/IIIa inhibitor: the GUSTO V study].
Franzosi MG
Ital Heart J Suppl; 2001 Sep; 2(9):1034-6. PubMed ID: 11675828
[No Abstract] [Full Text] [Related]
3. Reperfusion therapy for acute myocardial infarction with fibrinolytic therapy or combination reduced fibrinolytic therapy and platelet glycoprotein IIb/IIIa inhibition: the GUSTO V randomised trial.
Pereira H;
Rev Port Cardiol; 2001 Jun; 20(6):687-8. PubMed ID: 11525077
[No Abstract] [Full Text] [Related]
4. Glycoprotein IIb/IIIa antagonist and fibrinolytic agents: new therapeutic regimen for acute myocardial infarction.
Patel VB; Moliterno DJ
J Invasive Cardiol; 2000 Mar; 12 Suppl B():8B-15B. PubMed ID: 10731294
[No Abstract] [Full Text] [Related]
5. The GUSTO-V clinical trial.
Lincoff AM
J Invasive Cardiol; 2002 Feb; 14 Suppl A():21A-30A. PubMed ID: 11847403
[No Abstract] [Full Text] [Related]
6. ASSENT-3: implications for future trial design and clinical practice.
Van de Werf F
Eur Heart J; 2002 Jun; 23(12):911-2. PubMed ID: 12069439
[No Abstract] [Full Text] [Related]
7. Sonothrombolysis: a universally applicable and better way to treat acute myocardial infarction and stroke? Who is going to fund the research?
Kaul S
Circulation; 2009 Mar; 119(10):1358-60. PubMed ID: 19255337
[No Abstract] [Full Text] [Related]
8. Combination fibrinolytic therapy and platelet glycoprotein IIb/IIIa receptor blockade in acute myocardial infarction: an emerging solution for reperfusion.
Kaplan AL; Goldmann B; Ohman EM
J Emerg Med; 1999; 17(3):589-95. PubMed ID: 10338261
[No Abstract] [Full Text] [Related]
9. Toward a new frontier in myocardial reperfusion therapy: emerging platelet preeminence.
Topol EJ
Circulation; 1998 Jan; 97(2):211-8. PubMed ID: 9445175
[No Abstract] [Full Text] [Related]
10. [Risk stratification in the acute coronary syndrome. Diabetes--a diagnostic dilemma].
Giannitsis E; Katus HA
Dtsch Med Wochenschr; 2006 Nov; 131(47 Suppl 7):S211-4. PubMed ID: 17109251
[No Abstract] [Full Text] [Related]
11. Reperfusion synergism: will it be both sustained and safe?
Armstrong PW
Eur Heart J; 2000 Dec; 21(23):1913-6. PubMed ID: 11071795
[No Abstract] [Full Text] [Related]
12. [Pharmacological reperfusion in acute myocardial infarct].
Lorenzoni R; Gensini GF; De Caterina R
G Ital Cardiol; 1998 Dec; 28(12):1441-55. PubMed ID: 9887401
[No Abstract] [Full Text] [Related]
13. Fibrinolysis for acute myocardial infarction: the future is here and now.
Armstrong PW; Collen D; Antman E
Circulation; 2003 May; 107(20):2533-7. PubMed ID: 12777317
[No Abstract] [Full Text] [Related]
14. [Pharmacological thrombolysis in acute myocardial infarction. Lessons learned from ISIS-2 and GUSTO-1. I].
Jerjes-Sánchez C; Garza-Ruiz A; Gutiérrez-Fajardo P
Arch Inst Cardiol Mex; 1999; 69(5):478-87. PubMed ID: 10640212
[No Abstract] [Full Text] [Related]
15. Evolving antithrombotic treatment strategies for acute ST-elevation myocardial infarction.
Kandzari DE
Rev Cardiovasc Med; 2006; 7 Suppl 4():S29-37. PubMed ID: 17224888
[TBL] [Abstract][Full Text] [Related]
16. [Pharmacologic reperfusion in acute myocardial infarction].
Martínez Sánchez C
Arch Cardiol Mex; 2001; 71 Suppl 1():S131-5. PubMed ID: 11565318
[TBL] [Abstract][Full Text] [Related]
17. Acute myocardial infarction: early strategies to optimize results.
J Invasive Cardiol; 2005 May; 17(5):288-91. PubMed ID: 15879613
[No Abstract] [Full Text] [Related]
18. Platelet glycoprotein IIb/IIIa integrin inhibition in acute myocardial infarction.
O'Shea C; Tcheng JE
J Invasive Cardiol; 1999 Aug; 11(8):494-9. PubMed ID: 10745582
[No Abstract] [Full Text] [Related]
19. Fibrinolytic agents for the management of ST-segment elevation myocardial infarction.
Hilleman DE; Tsikouris JP; Seals AA; Marmur JD
Pharmacotherapy; 2007 Nov; 27(11):1558-70. PubMed ID: 17963464
[TBL] [Abstract][Full Text] [Related]
20. Pharmacoinvasive therapy: the future of treatment for ST-elevation myocardial infarction.
Antman EM; Van de Werf F
Circulation; 2004 Jun; 109(21):2480-6. PubMed ID: 15173037
[No Abstract] [Full Text] [Related]
[Next] [New Search]
